strip1 Antibody

Shipped with Ice Packs
In Stock

Description

What is Strip1 Antibody?

Strip1 antibodies are immunochemical tools designed to bind specifically to the Strip1 protein, which plays roles in cell survival, migration, and neural circuit development. Strip1 is conserved across species and interacts with STRIPAK components to regulate signaling pathways such as JNK/Jun-mediated apoptosis .

2.1. Neural Development

  • Retinal Ganglion Cell (RGC) Survival: Strip1 antibodies were used in zebrafish to demonstrate that loss of Strip1 triggers Jun-mediated apoptosis in RGCs, leading to disrupted inner plexiform layer (IPL) formation . Immunostaining confirmed Strip1 expression in RGCs and amacrine cells at 2 days post-fertilization (dpf) .

  • Cochlear Hair Cells: In mice, Strip1 antibodies revealed age-dependent expression in outer hair cells (OHCs) starting at postnatal day 14 (P14), with robust signals in both OHCs and inner hair cells (IHCs) by P21 .

2.2. Cell Migration and Cancer

  • Mesoderm Migration: Studies in Strip1-null mouse embryos showed disrupted mesoderm migration due to abnormal focal adhesions and actin cytoskeleton organization, validated using Strip1 antibodies in Western blot (WB) and immunofluorescence (IF) .

  • Cancer Metastasis: Strip1 knockdown in human cell lines reduced tumor growth by inducing cyclin-dependent kinase inhibitors, as confirmed via antibody-based assays .

Validation and Specificity

  • Western Blot: Strip1 antibodies detect bands at ~95 kDa in zebrafish, mouse, and human lysates . For example, the Novus OTI7B8 antibody recognizes recombinant human Strip1 (NP_149079) with high specificity .

  • Immunofluorescence: In zebrafish retinas, Strip1 antibodies labeled RGCs and amacrine cells, while blocking peptides eliminated signals, confirming specificity .

  • Negative Controls: Commercial antibodies (e.g., Boster A09470) show no cross-reactivity with unrelated proteins in Sox2-positive cochlear support cells .

Key Research Findings Using Strip1 Antibodies

Study ModelMajor FindingCitation
Zebrafish RetinaStrip1/STRIPAK suppresses Jun activation to prevent RGC apoptosis
Mouse CochleaStrip1 expression initiates in OHCs at P14, expanding to IHCs by adulthood
Mouse Embryonic FibroblastsStrip1 loss reduces cell spreading and focal adhesion density
Human Cancer CellsStrip1 depletion induces cell cycle arrest via cyclin-dependent kinases

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
strip1 antibody; fam40a antibody; Striatin-interacting protein 1 homolog antibody
Target Names
strip1
Uniprot No.

Target Background

Function
Strip1 Antibody may play a role in the regulation of cell morphology and cytoskeletal organization. It is required for the dynamics of cortical actin filaments and cell shape.
Database Links
Protein Families
STRIP family
Subcellular Location
Cytoplasm.

Q&A

What is Strip1 and what cellular functions does it regulate?

Strip1 is a core component of the STRIPAK complex involved in multiple cellular processes including embryogenesis, development, circadian rhythms, and has been implicated in conditions such as type 2 diabetes and cancer progression. As a scaffolding protein, Strip1 mediates interactions between striatin family proteins and other components of the STRIPAK complex. In the auditory system, Strip1 plays important roles in hair cell development and maturation, while in the visual system, it regulates retinal ganglion cell survival by suppressing Jun-mediated apoptosis .

What is the expression pattern of Strip1 during development?

Strip1 shows developmentally regulated expression in various tissues. In the mouse cochlea, both mRNA and protein expression of Strip1 increases with age starting from postnatal day 3 (P3), reaching peak expression levels at P30. Immunofluorescence studies reveal that Strip1 protein becomes detectable in outer hair cells (OHCs) starting at P14, with expression in both inner hair cells (IHCs) and OHCs evident from P21 onward . In zebrafish, Strip1 mRNA is both maternally and zygotically expressed, becoming restricted to the eyes, optic tectum, and heart by 2 days post-fertilization (dpf), with specific expression in retinal ganglion cells (RGCs) and amacrine cells (ACs) .

How should Strip1 antibody be used for immunofluorescent detection?

For optimal immunofluorescent detection of Strip1 in tissue samples, researchers should consider the following methodology:

  • Sample preparation: For whole-mount staining, fix tissue samples in 4% paraformaldehyde. For sectioning, prepare cryosections of appropriate thickness (typically 10-20 μm).

  • Antibody selection: Use validated Strip1-specific antibodies. Research has successfully employed commercially available antibodies for both mouse and zebrafish Strip1 detection.

  • Co-staining markers: Include cell-type specific markers such as Myo7a for hair cells and Sox2 for supporting cells when working with cochlear samples . For retinal tissues, markers for specific cell types (e.g., RGCs, ACs) should be included.

  • Imaging considerations: Since Strip1 expression varies between cell types and developmental stages, z-stack imaging may be necessary to capture complete expression patterns, particularly when examining structures with complex 3D organization .

What controls should be included when using Strip1 antibody?

When using Strip1 antibody for immunodetection, several controls are essential:

  • Negative controls: Include samples without primary antibody to assess non-specific binding of secondary antibodies.

  • Genetic controls: When available, use Strip1 knockout or knockdown tissues as negative controls to confirm antibody specificity.

  • Developmental stage controls: Include samples from multiple developmental stages, as Strip1 expression changes during development (e.g., P3 cochlear samples show minimal Strip1 expression and can serve as comparative controls) .

  • Cross-reactivity controls: Verify that the Strip1 antibody does not cross-react with other STRIPAK complex proteins, particularly Strip2, which is also expressed in some of the same cell types .

How can researchers address the embryonic lethality challenge when studying Strip1 function?

Homozygous Strip1 knockout (Strip1-/-) is embryonic lethal, presenting a significant challenge for studying Strip1 function in mature tissues. Studies have shown that when crossing Strip1 heterozygous knockout (Strip1+/-) mice, no homozygous knockouts were obtained, with the ratio of Strip1+/- to Strip1+/+ mice being approximately 2:1, confirming embryonic lethality . Researchers can address this challenge through:

  • Conditional knockout approaches: Generate Strip1-floxp mice and cross them with cell-type specific Cre lines (e.g., Atoh1-Cre for hair cell-specific deletion) .

  • Temporal control systems: Employ inducible Cre systems to delete Strip1 at specific developmental timepoints, avoiding early embryonic lethality.

  • Heterozygous models: Study Strip1+/- animals, although these may have normal phenotypes as observed in hearing function studies .

  • Alternative models: Use zebrafish or other model organisms where tissue-specific CRISPR-Cas9 approaches can be employed for temporal and spatial control of gene editing .

What methods are most effective for identifying Strip1-interacting proteins?

To identify Strip1-interacting proteins, researchers have successfully employed:

  • Co-immunoprecipitation coupled with mass spectrometry (Co-IP/MS): This approach has identified six proteins enriched only by wild-type Strip1, five of which are components of the STRIPAK complex .

  • Control considerations: Use multiple controls including:

    • Mutant Strip1-GFP pulldowns to identify proteins that interact non-specifically

    • GFP-only pulldowns to control for proteins that interact with the tag rather than Strip1

  • Validation approaches: Confirm interactions through:

    • Reverse Co-IP experiments

    • Functional studies (e.g., knockdown of potential interacting partners to see if they phenocopy Strip1 deficiency)

    • Expression correlation analysis using single-cell RNA sequencing data to identify co-expressed genes

How does Strip1 regulate cell survival pathways in neuronal cells?

Strip1 plays a critical role in promoting neuronal cell survival, particularly in retinal ganglion cells (RGCs). Research indicates that:

  • Mechanism of action: Strip1, likely through the STRIPAK complex, suppresses Jun-mediated proapoptotic signaling in RGCs during development .

  • Experimental evidence:

    • Strip1 mutant zebrafish show increased apoptosis in the ganglion cell layer (GCL)

    • This phenotype can be rescued by overexpressing the anti-apoptotic protein Bcl2, confirming that cell death is occurring through apoptotic pathways

  • Pathway analysis: Strip1 deficiency leads to upregulation of Jun protein, and pharmacological inhibition of Jun N-terminal kinase (JNK) significantly reduces apoptosis in Strip1 mutants .

  • Interacting partners: Knockdown of Strn3, a Strip1-interacting partner identified through Co-IP/MS, results in similar RGC apoptosis, suggesting a functional complex between these proteins in regulating cell survival .

How can researchers distinguish between the functions of Strip1 and other striatin-interacting proteins?

Distinguishing the specific functions of Strip1 from other striatin-interacting proteins requires careful experimental design:

  • Expression pattern analysis: Strip1 shows specific expression patterns that may differ from other family members. For example, Striatin (STRN) is specifically expressed in cell-cell junctions of inner hair cells, whereas Strip1 is expressed in both inner and outer hair cells .

  • Genetic approaches:

    • Generate specific knockouts/knockdowns for each family member

    • Create double or triple knockouts to identify redundant or unique functions

    • Use rescue experiments with individual family members in knockout backgrounds

  • Domain analysis: Create chimeric proteins or domain deletions to identify which regions of Strip1 mediate specific functions or interactions.

  • Cross-species comparison: Analyze conservation of function across model organisms, as some functions may be species-specific while others are universal .

What are the optimal methods for quantifying Strip1 expression levels in different experimental contexts?

For accurate quantification of Strip1 expression:

  • mRNA expression:

    • Real-time qPCR has successfully been used to quantify Strip1 mRNA expression across developmental stages

    • For tissue-specific or cell-type specific analysis, single-cell RNA sequencing provides higher resolution data on expression patterns

  • Protein expression:

    • Western blotting with appropriate normalization to housekeeping proteins

    • Quantitative immunofluorescence using standardized imaging parameters and analyzing fluorescence intensity

  • Developmental analysis:

    • When studying developmental changes, maintain consistent experimental conditions across all timepoints

    • Include multiple timepoints to capture the complete expression profile (e.g., P3, P7, P14, P21, P30, and P60 for mouse cochlear studies)

  • Data analysis considerations:

    • Use appropriate statistical tests for comparing expression levels

    • Consider biological replicates from multiple animals to account for individual variation

    • For immunofluorescence quantification, analyze multiple sections/regions per sample

What are the key considerations when designing Strip1 knockout or knockdown experiments?

When designing genetic manipulation experiments for Strip1, researchers should consider:

  • Complete knockout considerations:

    • Embryonic lethality of Strip1-/- requires alternative approaches

    • Potential compensatory mechanisms by related proteins (e.g., Strip2)

  • Conditional knockout strategies:

    • Selection of appropriate Cre driver lines based on research question (e.g., Atoh1-Cre for hair cell-specific deletion)

    • Temporal control using inducible systems to bypass developmental requirements

  • Knockdown approaches:

    • Morpholino design for zebrafish studies, with appropriate controls for specificity

    • siRNA or shRNA approaches for cell culture models

  • Validation of genetic manipulation:

    • Confirmation of reduced Strip1 levels using qPCR, western blotting, and immunofluorescence

    • Inclusion of rescue experiments to confirm specificity of observed phenotypes

How can researchers address non-specific binding issues with Strip1 antibodies?

Non-specific binding is a common challenge with antibodies. For Strip1 antibodies:

  • Validation approaches:

    • Use genetic models (knockouts/knockdowns) as negative controls

    • Perform peptide competition assays to confirm specificity

    • Test multiple antibodies targeting different epitopes

  • Optimization strategies:

    • Titrate antibody concentrations to minimize background

    • Modify blocking conditions (duration, composition of blocking solution)

    • Adjust washing steps (number, duration, detergent concentration)

  • Sample-specific considerations:

    • For tissues with known low or absent Strip1 expression (e.g., supporting cells in cochlea), verify absence of signal

    • For developmental studies, include early timepoints with minimal Strip1 expression as internal controls

What are the potential pitfalls when interpreting Strip1 knockout phenotypes?

When interpreting phenotypes in Strip1 knockout/knockdown models, consider:

  • Primary vs. secondary effects:

    • In zebrafish Strip1 mutants, IPL (inner plexiform layer) defects persist even when apoptosis is prevented by Bcl2 overexpression, suggesting separate roles for Strip1 in cell survival and neurite patterning

    • Distinguish cell-autonomous effects from those caused by disruption of neighboring cells

  • Compensatory mechanisms:

    • Strip1+/- mice show normal hearing and hair cell numbers despite reduced Strip1 levels, suggesting compensation

    • Consider potential upregulation of related proteins like Strip2

  • Developmental timing:

    • Strip1 expression changes throughout development, so phenotypes may differ depending on when function is disrupted

    • Early effects may cascade to cause secondary phenotypes later in development

  • Tissue interactions:

    • In retina, Strip1 in RGCs affects laminar positioning of other retinal neurons and IPL integrity

    • Consider how cell-type specific manipulations may affect tissue architecture

How does Strip1 function in the STRIPAK complex relate to broader cellular signaling networks?

Strip1 functions within the larger context of STRIPAK complex signaling:

  • STRIPAK components:

    • Strip1 co-immunoprecipitation studies identified five STRIPAK components as interacting partners

    • Only Strip1 and Strn3 show abundant expression in zebrafish embryonic retinal cells

  • Integration with apoptotic pathways:

    • Strip1 suppresses Jun-mediated proapoptotic signaling

    • This suggests cross-talk between STRIPAK signaling and stress-response pathways

  • Developmental regulation:

    • Strip1 expression is developmentally regulated in multiple tissues

    • This temporal regulation may coordinate with other developmental signaling pathways

  • Research approaches:

    • Systems biology approaches (protein interaction networks, pathway analysis)

    • Comparative studies across different cell types and organisms

    • Integration of genetic, biochemical, and cell biological data

What emerging technologies might advance Strip1 antibody-based research?

Future Strip1 research may benefit from:

  • Advanced imaging techniques:

    • Super-resolution microscopy to resolve subcellular localization

    • Live-cell imaging with tagged Strip1 to track dynamics

    • Expansion microscopy for improved spatial resolution in complex tissues

  • Proximity labeling approaches:

    • BioID or APEX2 fusions to identify proximity partners in living cells

    • More comprehensive identification of the Strip1 interactome in different cell types

  • Single-cell technologies:

    • Single-cell proteomics to complement existing RNA-seq data

    • Spatial transcriptomics to map Strip1 expression in intact tissues

  • CRISPR technologies:

    • Base editing or prime editing for more precise genetic manipulation

    • CRISPR activation/inhibition systems to modulate Strip1 expression without genetic deletion

How can researchers reconcile contradicting data about Strip1 function across different model systems?

When facing contradictory data about Strip1 across different models:

  • Species-specific differences:

    • Compare Strip1 sequences across species to identify conserved vs. divergent domains

    • Consider evolutionary adaptations that might alter Strip1 function

  • Context-dependent functions:

    • Strip1 may interact with different partners in different cell types

    • Expression levels of interacting proteins may vary across tissues

  • Methodological considerations:

    • Different knockout strategies may result in different phenotypes

    • Antibody specificity may vary across species or applications

  • Integrative approaches:

    • Use complementary methods to address the same question

    • Consider genetic interaction studies to map functional relationships

    • Employ rescue experiments with constructs from different species

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.